DeepIntent Launches Cortex™
Re-engineering Their DSP for the Healthcare Media Market
DeepIntent, a prominent player in healthcare advertising technology, has announced the launch of DeepIntent Cortex™, a major upgrade to its demand side platform (DSP). The new platform was unveiled at the company’s AdLab event in New York on March 25.
Cortex is positioned as a next-generation DSP, integrating AI with real-time media buying and refreshed health data to help healthcare marketers deliver more personalized campaigns. According to DeepIntent, the platform connects marketing performance directly to real-world health outcomes, promising faster insights, improved efficiency, and increased scale for advertisers working in the pharma and life sciences industries.
The launch follows nearly two years of development, with Cortex offering several new capabilities aimed at streamlining workflows, enhancing audience targeting, and optimizing campaign performance through what the company calls “Health Intelligent™” media buying.
Key features include:
-
AI-powered automation for campaign setup and optimization, which the company claims can reduce management time by up to 50%.
-
Predictive AQ Optimization, allowing marketers to anticipate the impact of ad quality improvements before launching media buys.
-
HealthFirst™ Packages, curated media marketplaces for access to premium endemic and connected TV inventory.
-
Enhanced HCP (healthcare provider) targeting with advanced analytics tools and a new NPI-based site dashboard.
At launch, DeepIntent highlighted early performance metrics, including a reported 25% improvement in optimization outcomes and an 80% lift in average audience quality during internal testing.
With Cortex, DeepIntent is aiming to position itself at the forefront of programmatic media buying in the healthcare sector—an area seeing increased demand for precision, data transparency, and measurable impact.
